Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Oktober 2017

Planlagt Fastgjort Låst Flyttet Genmab
2.7k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • G Offline
    G Offline
    GeorgeBest
    wrote on sidst redigeret af
    #2666

    Jeg ved JKY. Men hvor tit skal patienten have Revlimid? Hvor tit skal han have dex?

    1 Reply Last reply
    0
    • J Offline
      J Offline
      JKY_VH
      wrote on sidst redigeret af
      #2667

      Mon det er helt standardiseret?

      1 Reply Last reply
      0
      • BulderB Offline
        BulderB Offline
        Bulder
        wrote on sidst redigeret af
        #2668

        Det vil jo nok vise sig med Cassiopeia, som er for transplantationsegnede, hvor vedligeholdelse kommer ind i billedet. I studiet er vedligeholdelse beskrevet som 16 mg (dvs 1 infusion) hver ottende uge i 2 år. https://www.clinicaltrials.gov/ct2/show/NCT02541383?term=cassiopeia&rank=1

        1 Reply Last reply
        0
        • BulderB Offline
          BulderB Offline
          Bulder
          wrote on sidst redigeret af
          #2669

          I MMY2004 D-RVd, er dara vedligehold ligeledes hver 8. uge. Revlimid vedligehold er oftere https://www.clinicaltrials.gov/ct2/show/NCT02874742?term=mmy2004&rank=1

          1 Reply Last reply
          0
          • BulderB Offline
            BulderB Offline
            Bulder
            wrote on sidst redigeret af
            #2670

            maintenance treatment with lenalidomide 10 mg on days 1-21 daily up to 32 cycles and each cycle is of 28-days. Beginning at Cycle 10, the lenalidomide dose will be increased to 15 mg unless there is a tolerability concern.

            1 Reply Last reply
            0
            • MrEbbeM Offline
              MrEbbeM Offline
              MrEbbe
              wrote on sidst redigeret af
              #2671

              Er her en der kan opdatere os på AMG 714, hvad er potentialet i det, og hvornår kan vi forvente konklusion på deres fase 2 studier?

              1 Reply Last reply
              0
              • BulderB Offline
                BulderB Offline
                Bulder
                wrote on sidst redigeret af
                #2672

                Så får jeg det til at de får op til 189 piller a 10 mg og 462 piller a 15 mg. Hvis jeg har forstået det rigtigt. Jeg ved ikke hvad en pille koster.

                1 Reply Last reply
                0
                • A Offline
                  A Offline
                  AaBforever
                  wrote on sidst redigeret af
                  #2673

                  10 mg koster dkk 2614 og 15 mg dkk 2751 if
                  lg. mdecincinpriser.dk

                  1 Reply Last reply
                  0
                  • J Offline
                    J Offline
                    JKY_VH
                    wrote on sidst redigeret af
                    #2674

                    tak Bulder og Aab

                    1 Reply Last reply
                    0
                    • BulderB Offline
                      BulderB Offline
                      Bulder
                      wrote on sidst redigeret af
                      #2675

                      Det bliver så knap 1.8 mio for en fuld Rev-vedligehold.

                      1 Reply Last reply
                      0
                      • BulderB Offline
                        BulderB Offline
                        Bulder
                        wrote on sidst redigeret af
                        #2676

                        Meget passende kommer de i 21-styks pakninger.

                        1 Reply Last reply
                        0
                        • R Offline
                          R Offline
                          Raffles
                          wrote on sidst redigeret af
                          #2677

                          Halozymes today announced that Janssen has initiated the first of three planned Phase 3 clinical trials evaluatin a subcutaneous (SC) delivery of Darzalex with Halozymes proprietary ENHANZE technology.
                          The initial Phase 3 study is in amyloidosis with additional Phase 3 studies in multiple myeloma and smoldering myeloma patients planned for near-term initiation.

                          1 Reply Last reply
                          0
                          • R Offline
                            R Offline
                            Raffles
                            wrote on sidst redigeret af
                            #2678

                            Janssen pay a USD 15 million milestone payment to Halozyme after enrollment of three patients.

                            1 Reply Last reply
                            0
                            • B Offline
                              B Offline
                              bibob
                              wrote on sidst redigeret af
                              #2679

                              Lyder godt Raffles. Tak for den. 🙂

                              1 Reply Last reply
                              0
                              • J Offline
                                J Offline
                                JKY_VH
                                wrote on sidst redigeret af
                                #2680

                                jep, også tak herfra

                                1 Reply Last reply
                                0
                                • N Offline
                                  N Offline
                                  nsrafk
                                  wrote on sidst redigeret af
                                  #2681

                                  Har det noget med genmab at gøre?

                                  1 Reply Last reply
                                  0
                                  • SolsenS Offline
                                    SolsenS Offline
                                    Solsen
                                    wrote on sidst redigeret af
                                    #2682

                                    Med nuværende problemer, som er vanskelige at se en løsning på vil CAR-T aldrig have en chance i firstline, når alternativet er en sikker behandling. Tænk på hvor enkelt en sc-dara og rev pille vil være first line. I denne behandling og måske også med Velcade vil en pæn del af patienterne også blive helbredt.

                                    1 Reply Last reply
                                    0
                                    • R Offline
                                      R Offline
                                      Raffles
                                      wrote on sidst redigeret af
                                      #2683

                                      @nsrafk, første patient i Ph 3 studiet af subcutan DARA er i gang med behandlingen

                                      1 Reply Last reply
                                      0
                                      • N Offline
                                        N Offline
                                        nsrafk
                                        wrote on sidst redigeret af
                                        #2684

                                        Cool. Tak for info

                                        1 Reply Last reply
                                        0
                                        • B Offline
                                          B Offline
                                          bibob
                                          wrote on sidst redigeret af
                                          #2685

                                          Just a moment...

                                          favicon

                                          (www.streetinsider.com)

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger